FILE PHOTO: The logo of Swiss specialty chemicals company Clariant is seen at the company’s headquarters in Pratteln, Switzerland October 29, 2017. REUTERS/Arnd Wiegmann ZURICH (Reuters) – Clariant (CLN.S) on Friday rejected its largest shareholder White Tale’... More »
Activist investor White Tale on Monday demanded three seats on Clariant's board and an independent strategic review of the Swiss speciality chemicals group after thwarting its plans to merge with U.S. peer Huntsman in a $20 billion deal. More »
Swiss specialty chemicals maker Clariant and U.S. group Huntsman abandoned their $20 billion merger on Friday, notching a win for activist investors who fought the deal for months on the grounds it would destroy shareholder value. More »
Swiss specialty chemicals maker Clariant and Huntsman have agreed to abandon their proposed $20 billion merger, bowing to a growing number of shareholders who had joined activist investor White Tale to oppose the deal. More »
Activist investors who oppose Swiss specialty chemicals maker Clariant's proposed $20 billion merger with U.S.-based Huntsman have boosted their stake to 20 percent, the Swiss stock exchange said on Friday, after Reuters reported the increased holding on Thurs... More »
Activist investors seeking to block specialty chemical maker Clariant's $20 billion merger with Huntsman Corp have boosted their stake in the Swiss group above 20 percent, triggering an official disclosure filing, a source familiar with the matter said. More »
